"10.1371_journal.pone.0107995","plos one","2014-09-25T00:00:00Z","Yoichi Takakusagi; Shingo Matsumoto; Keita Saito; Masayuki Matsuo; Shun Kishimoto; Jonathan W Wojtkowiak; William DeGraff; Aparna H Kesarwala; Rajani Choudhuri; Nallathamby Devasahayam; Sankaran Subramanian; Jeeva P Munasinghe; Robert J Gillies; James B Mitchell; Charles P Hart; Murali C Krishna","Radiation Biology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, United States of America; National Institute of Neurological Diseases and Stroke, Bethesda, Maryland, United States of America; Threshold Pharmaceuticals, South San Francisco, California, United States of America","Conceived and designed the experiments: YT SM KS JBM MCK. Performed the experiments: YT SM KS MM SK JWW WD AHK. Analyzed the data: YT SM KS MM SK JWW WD AHK RJG JBM CPH MCK. Contributed reagents/materials/analysis tools: SM WD RC ND SS JPM RJG JBM CPH MCK. Contributed to the writing of the manuscript: YT WD MCK.","C.P. Hart is employed by Threshold Pharmaceuticals. TH-302 was received from Threshold Pharmaceuticals through a materials transfer agreement with NIH. This does not alter the authors adherence to PLOS ONE polices on sharing data and materials.","2014","09","Yoichi Takakusagi","YT",16,TRUE,5,8,12,NA,TRUE,TRUE,FALSE,0,NA,FALSE
